Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ørjan Samuelsen

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Journal of Microbiological Methods|January 24, 2018
Detection of carbapenemases with a newly developed commercial assay using Matrix Assisted Laser Desorption Ionization-Time of FlightEllionor Rapp, Ørjan Samuelsen, Martin Sundqvist
Journal of Global Antimicrobial Resistance|February 11, 2021
Evaluation of the Amplex eazyplex® SuperBug Acineto test for detection of acquired OXA and NDM carbapenemases in Acinetobacter sppBjørg C Haldorsen, Jessin Janice, Ørjan Samuelsen
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 31, 2012
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumanniiNabil Karah, Arnfinn Sundsfjord, Kevin Towner, et al.
Genome Announcements|July 8, 2017
Complete Genome Sequence of a Multidrug-Resistant, <i>bla</i><sub>NDM-1</sub>-Expressing <i>Klebsiella pneumoniae</i> K66-45 Clinical Isolate from NorwayAdam Heikal, Ørjan Samuelsen, Tom Kristensen, et al.
Diagnostic Microbiology and Infectious Disease|February 4, 2012
Fecal colonization of VIM-1-producing Klebsiella pneumoniae and in vivo transfer of multidrug-resistant IncN plasmid in a renal transplant patientUmaer Naseer, Bjørn Odvar Eriksen, Arnfinn Sundsfjord, et al.
Infectious Diseases (London, England)|September 29, 2015
The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011Ilya Nikolaevich Zykov, Arnfinn Sundsfjord, Lars Småbrekke, et al.
Current Microbiology|September 24, 2017
Use of a Commercially Available Microarray to Characterize Antibiotic-Resistant Clinical Isolates of Klebsiella pneumoniaeColin Charnock, Ørjan Samuelsen, Anne-Lise Nordlie, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 12, 2011
A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineagesNabil Karah, Christian G Giske, Arnfinn Sundsfjord, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase familyØrjan Samuelsen, Mariana Castanheira, Timothy R Walsh, et al.
Scientific Reports|June 11, 2020
Host dependent maintenance of a bla<sub>NDM-1</sub>-encoding plasmid in clinical Escherichia coli isolatesJoão Alves Gama, Julia Kloos, Pål J Johnsen, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Journal of Microbiological Methods|January 24, 2018
Detection of carbapenemases with a newly developed commercial assay using Matrix Assisted Laser Desorption Ionization-Time of FlightEllionor Rapp, Ørjan Samuelsen, Martin Sundqvist
Journal of Global Antimicrobial Resistance|February 11, 2021
Evaluation of the Amplex eazyplex® SuperBug Acineto test for detection of acquired OXA and NDM carbapenemases in Acinetobacter sppBjørg C Haldorsen, Jessin Janice, Ørjan Samuelsen
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 31, 2012
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumanniiNabil Karah, Arnfinn Sundsfjord, Kevin Towner, et al.
Genome Announcements|July 8, 2017
Complete Genome Sequence of a Multidrug-Resistant, <i>bla</i><sub>NDM-1</sub>-Expressing <i>Klebsiella pneumoniae</i> K66-45 Clinical Isolate from NorwayAdam Heikal, Ørjan Samuelsen, Tom Kristensen, et al.
Diagnostic Microbiology and Infectious Disease|February 4, 2012
Fecal colonization of VIM-1-producing Klebsiella pneumoniae and in vivo transfer of multidrug-resistant IncN plasmid in a renal transplant patientUmaer Naseer, Bjørn Odvar Eriksen, Arnfinn Sundsfjord, et al.
Infectious Diseases (London, England)|September 29, 2015
The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011Ilya Nikolaevich Zykov, Arnfinn Sundsfjord, Lars Småbrekke, et al.
Current Microbiology|September 24, 2017
Use of a Commercially Available Microarray to Characterize Antibiotic-Resistant Clinical Isolates of Klebsiella pneumoniaeColin Charnock, Ørjan Samuelsen, Anne-Lise Nordlie, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 12, 2011
A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineagesNabil Karah, Christian G Giske, Arnfinn Sundsfjord, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2008
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase familyØrjan Samuelsen, Mariana Castanheira, Timothy R Walsh, et al.
Scientific Reports|June 11, 2020
Host dependent maintenance of a bla<sub>NDM-1</sub>-encoding plasmid in clinical Escherichia coli isolatesJoão Alves Gama, Julia Kloos, Pål J Johnsen, et al.
Pageof 11